| Item number | Description | Units per box |
|---|---|---|
| 7209509 | TruClear™ soft tissue shaver plus | 1 |
| 72202536 | TruClear™ soft tissue shaver mini | 1 |
Intrauterine tissue removal
TruClear™ soft tissue shaver
<p>TruClear™ soft tissue shavers provide tissue removal in hysteroscopic procedures and comes in both a plus and mini size.</p>
The TruClear™ tissue shaver technology
More options mean more control in every procedure.
When used with the TruClear™ system, our soft tissue shavers can provide complete pathology removal.1
All TruClear™ soft tissue shavers offer:
- Simultaneous tissue cutting and aspiration to reduce procedure time compared to electrical resection2
- Proprietary suction control feature - suction is only activated while cutting is in progress
- TruClear™ soft tissue shaver mini cutting window is 5 mm
- TruClear™ soft tissue shaver plus cutting window is 7 mm
| Name | TruClear™ soft tissue shaver mini | TruClear™ soft tissue shaver plus |
|---|---|---|
| Average tissue removal rate† | 4.2 g/min3 (analog tissue) | 17 g/min3 (analog tissue) |
Ordering information
Related products
-
HysteroLux™ fluid management systemThe HysteroLux™ system enables uterine distention while monitoring a patient’s fluid deficit in real-time during hysteroscopic procedures.
-
TruClear™ 5C hysteroscope setThe smaller diameter TruClear™ 5C hysteroscope set enables a see-and-treat approach to intrauterine pathologies.
-
TruClear™ Elite hysteroscopeThe TruClear™ Elite hysteroscopes enable a see-and-treat approach for intrauterine pathologies.
-
TruClear™ hysteroscope set duoThe smallest diameter hysteroscope in the TruClear™ portfolio, TruClear™ set duo provides the option of a diagnostic or operative sheath for the office setting.
-
TruClear™ hysteroscopic tissue removal systemThe TruClear™ system offers a complete solution for diagnosing and treating intrauterine abnormalities that may be causing abnormal uterine bleeding.
Adverse effects for operative hysteroscopy include but are not limited to fluid overload due to intravasation and uterine perforation. Please refer to instructions for use (IFU) for complete contraindication and risk information. Residual risks to the patients may include but are not limited to exposure to body fluids, laceration, and carcinogen exposure.
†The study was conducted in an in vitro setting created to resemble the clinical setting of operative hysteroscopy. This study's results may or may not necessarily be indictative of clinical performance.
- Hamerlynck TW, Blikkendaal MD, Schoot BC, Hanstede MM, Jansen FW. An alternative approach for removal of placental remnants: hysteroscopic morcellation. J Minim Invasive Gynecol. 2013 Nov-Dec;20(6):796-802.
- Smith PP, Middleton LJ, Connor M, Clark TJ. Hysteroscopic morcellation compared with electrical resection of endometrial polyps: a randomized controlled trial. Obstet Gynecol. 2014 Apr;123(4):745-51.
- 15002084 TRUCLEAR 8 0 system resection rate of polyps 082213 (v1.0) - Average 4 g/min (p.10)